We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Updates C. Difficile Guidance in Light of Newer Technologies
FDA Updates C. Difficile Guidance in Light of Newer Technologies
December 8, 2010
Recognizing new issues facing sponsors of diagnostics to detect Clostridium difficile infections, the FDA has updated its 20-year-old guidance on establishing the performance characteristics of new tests.